Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT00606684
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 14 de sept de 2023
ID: NCT06003426
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01968733
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)
INTERVENTIONAL
Inicio: 17 de jul de 2025
ID: NCT06765109
Completado
Fase 2
ClinicalTrials.gov
A 6-month Randomized, Double-blind, Parallel-group, Multicentre, Placebo-controlled Phase II Study to Compare Anti-asthmatic Effect and Safety of Esomeprazole (Nexium®) 40 mg Twice Daily or 40 mg Once Daily With Placebo in Adults With Asthma
INTERVENTIONAL
Inicio: 1 de abr de 2006
ID: NCT00317044
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis - The ASPEN Study
INTERVENTIONAL
Inicio: 1 de dic de 2020
ID: NCT04594369
Completado
Fase 3
ClinicalTrials.gov
A Comparison of Symbicort® SMART (160/4.5μg) and Symbicort® Turbuhaler 160/4.5 μg, Plus Terbutaline Turbuhaler 0.4 mg as Needed, for Treatment of Asthma - a 12-month, Randomized, Double-blind, Parallel Group, Active-controlled, Multinational Phase III Study in Asthmatic Patients From 16 Years
INTERVENTIONAL
Inicio: 1 de feb de 2009
ID: NCT00839800
Completado
Fase 3
ClinicalTrials.gov
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
INTERVENTIONAL
Inicio: 18 de abr de 2020
ID: NCT04535063
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Phase Ib/III Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous Compared With Atezolizumab Intravenous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 27 de dic de 2018
ID: NCT03735121
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of EDP-938 Administered Orally for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Ambulatory Adult Subjects (RSVP)
INTERVENTIONAL
Inicio: 22 de ene de 2020
ID: NCT04196101
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter Variable Length Study to Assess the Efficacy and Safety of PT010 Relative to PT009 and Symbicort® in Adult and Adolescent Participants With Inadequately Controlled Asthma
INTERVENTIONAL
Inicio: 15 de dic de 2020
ID: NCT04609878
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Effect of 12 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5/5 µg and 5/5 µg) Delivered by the Respimat® Inhaler, on Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD)[Torracto (TM)]
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01525615
Completado
Fase 2
ClinicalTrials.gov
Phase 2, Randomized, Controlled, Open Label Multi-center Study to Assess Efficacy and Safety of DFV890 for the Treatment of SARS-CoV-2 Infected Patients With COVID-19 Pneumonia and Impaired Respiratory Function
INTERVENTIONAL
Inicio: 27 de may de 2020
ID: NCT04382053
Completado
Fase 3
ClinicalTrials.gov
A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00578786
Completado
Fase 3
ClinicalTrials.gov
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Subjects With Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 5 de ago de 2015
ID: NCT02477826
Completado
Fase 3
ClinicalTrials.gov
A Pivotal Phase 3 Study of MEDI-524 (Numax; Motavizumab), an Enhanced Potency Humanized RSV Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
INTERVENTIONAL
Inicio: 1 de nov de 2004
ID: NCT00129766
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, International Study of Osimertinib as Maintenance Therapy in Patients With Locally Advanced, Unresectable EGFR Mutation-positive Non-Small Cell Lung Cancer (Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy (LAURA).
INTERVENTIONAL
Inicio: 19 de jul de 2018
ID: NCT03521154
Completado
Fase 3
ClinicalTrials.gov
A Phase II/III Double Blind Randomized Trial of AZD2171 Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 3 de nov de 2005
ID: NCT00245154
Completado
Fase 3
ClinicalTrials.gov
PONENTE: A Multicenter, Open-label, Phase 3b Efficacy and Safety Study of Benralizumab 30 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Patients With Severe Eosinophilic Asthma on High Dose Inhaled Corticosteroid Plus Long-acting β2 Agonist and Chronic Oral Corticosteroid Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2018
ID: NCT03557307
Completado
Fase 2
ClinicalTrials.gov
A Multi-center, Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of Macitentan in Subjects With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
INTERVENTIONAL
Inicio: 11 de jul de 2017
ID: NCT03153111
Anterior
1
...
28
29
30
...
434
Siguiente
Filtros